These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 4877784)

  • 1. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.
    Ritchie DM; Boyle JA; McInnes JM; Jasani MK; Dalakos TG; Grieveson P; Buchanan WW
    Q J Med; 1968 Jul; 37(147):393-406. PubMed ID: 4877784
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a simple articular index for joint tenderness in rheumatoid arthritis.
    Ritchie DA; Boyle JA; McInnes JM; Jasani MK; Dalakos TG; Grieveson P; Buchanan WW
    Ann Rheum Dis; 1969 Mar; 28(2):196. PubMed ID: 4887770
    [No Abstract]   [Full Text] [Related]  

  • 3. International symposium on levamisole in rheumatoid arthritis. A review of short and longterm effects on articular manifestations.
    Basch CM; Spitler LE; Engleman EP
    J Rheumatol Suppl; 1978; 4():11-6. PubMed ID: 366136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted assessment of the temporomandibular joint in patients with rheumatoid arthritis.
    Bessa-Nogueira RV; Vasconcelos BC; Duarte AP; Góes PS; Bezerra TP
    J Oral Maxillofac Surg; 2008 Sep; 66(9):1804-11. PubMed ID: 18718386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of drug efficacy in rheumatoid arthritis.
    Decker JL; Mainland D
    N Engl J Med; 1970 Oct; 283(17):928-9. PubMed ID: 4917726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of glucocorticoids in rheumatoid arthritis].
    Jacobsen S
    Ugeskr Laeger; 2000 Feb; 162(6):770-2. PubMed ID: 10689949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.
    del Toro RA; Concepción R
    Clin Ther; 1983; 5(4):436-44. PubMed ID: 6223699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a functional index in rheumatoid arthritis.
    Lee P; Jasani MK; Dick WC; Buchanan WW
    Scand J Rheumatol; 1973; 2(2):71-7. PubMed ID: 4584370
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint counts and physical measures.
    Fuchs HA
    Rheum Dis Clin North Am; 1995 May; 21(2):429-44. PubMed ID: 7631037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin in rheumatoid arthritis, a seven-day, double-blind trial--preliminary report.
    Mainland D; Sutcliffe MI
    Bull Rheum Dis; 1965 Nov; 16(3):388-91. PubMed ID: 5318934
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation of patient-reported joint counts in rheumatoid arthritis and the role of training.
    Levy G; Cheetham C; Cheatwood A; Burchette R
    J Rheumatol; 2007 Jun; 34(6):1261-5. PubMed ID: 17444590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of GP-40705 in rheumatoid arthritis].
    Badia Flores J
    Prensa Med Mex; 1969; 34(9):382-4. PubMed ID: 4907856
    [No Abstract]   [Full Text] [Related]  

  • 14. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
    Edwards W
    Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis.
    Lee P; Webb J; Anderson J; Buchanan WW
    Br Med J; 1973 Jun; 2(5868):685-8. PubMed ID: 4582051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritis.
    Bunn DK; Shepstone L; Galpin LM; Wiles NJ; Symmons DP
    Rheumatology (Oxford); 2004 Dec; 43(12):1519-25. PubMed ID: 15316124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical approach to indices of disease activity in rheumatoid arthritis.
    McGuire RJ; Wright V
    Ann Rheum Dis; 1971 Nov; 30(6):574-80. PubMed ID: 4943205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with sulindac in rheumatoid arthritis and osteoarthritis].
    Huskisson EC
    Reumatizam; 1980; 27(2):35-7. PubMed ID: 6996064
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of joint inflammation. Local 99mTc indices of knees, hands, elbows and feet.
    Rekonen A; Kuikka J; Oka M
    Scand J Rheumatol; 1974; 3(2):75-8. PubMed ID: 4609320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.